Literature DB >> 29778185

Serine 105 and 120 are important phosphorylation sites for porcine reproductive and respiratory syndrome virus N protein function.

Yao Chen1, Xiulin Xing1, Qi Li1, Songlin Feng1, Xiaoliang Han1, Shuyi He1, Guihong Zhang2.   

Abstract

The nucleocapsid (N) protein is the most abundant protein of porcine reproductive and respiratory syndrome virus (PRRSV). It has been shown to be multiphosphorylated. However, the phosphorylation sites are still unknown. In this study, we used liquid chromatography tandem mass spectrometry (LC-MS/MS) to analyze the phosphorylation sites of N protein expressed in Sf9 cells. The results showed that N protein contains two phosphorylation sites. Since N protein can regulate IL-10, which may facilitate PRRSV replication, we constructed four plasmids (pCA-XH-GD, pCA-A105, pCA-A120 and pCA-A105-120) and transfected them into Pig alveolar macrophages (PAMs,3D4/2). The qPCR results showed that mutations at residues 105 and 120 were associated with down-regulation of the IL-10 mRNA level, potentially decreasing the viral growth ability. Then, we mutated the phosphorylation sites (S105A and S120A) and rescued three mutated viruses, namely, A105, A120 and A105-120. Compared with wild-type virus titers, the titers of the mutated viruses at 48 hpi were significantly decreased. The Nsp(non-structural protein) 9 qPCR results were consistent with the multistep growth kinetics results. The infected PAMs (primary PAMs) results were similar with Marc-145.The findings indicated that the mutations impaired the viral replication ability. The confocal microscopy results suggested that mutations to residues 105 and 120 did not affect N protein distribution. Whether the mutations affected other functions of N protein and what the underlying mechanisms are need further investigation. In conclusion, our results show that residues 105 and 120 are phosphorylation sites and are important for N protein function and for viral replication ability.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  N protein; PRRSV; Phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 29778185      PMCID: PMC7117435          DOI: 10.1016/j.vetmic.2018.04.010

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


Introduction

Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped, positive-stranded virus (Kvisgaard et al., 2017). PRRSV, lactate dehydrogenase-elevating virus (LDV), simian hemorrhagic fever virus (SHFV), and equine arteritis virus (EAV) are members of family Arteriviridae. PRRSV has two types: the EU type and the NA type (Xie et al., 2017). PRRSV contains 14 non-structural proteins and 7 structural proteins (Chen et al., 2016). The nucleocapsid (N) protein, which is the most abundant protein in the virus particle, is a 15 kD protein (Doan and Dokland, 2003) of 123 or 128 aa. The N protein is important for virus assembly (Snijder et al., 2013). It can regulate IL-10 and enhance regulatory T lymphocyte proliferation, when residues 15 and 46 are mutated (Fan et al., 2015). N also has been found to be connected with Nsp9, Nsp10 and viral RNA (Chen et al., 2017; Liu et al., 2016; Wang et al., 2012). The N protein has been proven to be multiphosphorylated (Wootton et al., 2002). Moreover, the serine 120 was proven to be a phosphorylation site that, if mutated,impairs viral growth ability (Liu et al., 2017). The other modifications of the N protein are still unknown. Knowledge of the modifications of N protein are fundamental to understanding the PRRSV life cycle. However, the post-translational and other modification sites of N protein are still unclear, especially the phosphorylation sites. To date, mass spectrometry has proved to be a powerful tool in the analysis of protein phosphorylation sites (Bittremieux et al., 2017). Since N protein is difficult to purify from virions (Chen et al., 2005), in this research, a baculovirus expression system, which is widely used in analyzing post-translational protein modifications, was used to express the N protein (Peng et al., 2012; Zhang et al., 2017). We used liquid chromatography tandem mass spectrometry (LC–MS/MS) to identify the modification sites of N protein expressed in Sf9 cells. The analysis achieved 85% coverage of the N protein and identified two phosphorylation sites, namely, residues 105 and 120. Our results show that residue 105 is a phosphorylation site and that residues 105 and 120 are important for N protein function.

Materials and methods

Virus and cells

Sf9 cells were maintained in SF900TM SFM II medium (Gibco, USA) at 27 °C. PAMs (ATCC,3D4/2) (Yu et al., 2017), PAMs (primary PAMs) and Marc-145 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco), supplemented with 10% fetal bovine serum (FBS, BI, Israel) at 37 °C in 5% CO2. XH-GD (GenBank accession no. EU624117.1) was used in the virus infection studies.

Plasmid construction and DNA transfection

To synthesize the recombinant PRRSV N protein from Sf9 cells, the N genes of XH-GD were amplified with specific primers (Table 1 ) and cloned into the pFastBac Dual vector (Invitrogen, USA) or pCAGGS-MCS vector. The forward primers contained a Kozak sequence, and the reverse primers contained a 6 × His Tag. Recombinant baculoviruses were obtained using the Bac-to-Bac Baculovirus Expression System (Invitrogen, USA) according to the manufacturer’s protocol. The cells were collected at 72 h post-transfection (Fan et al., 2015). For transfection of PAMs(3D4/2), the cell were spilt into 6-well plate. Plasmids (pCA-XH-GD, pCA-A105, pCA-A120 and pCA-A105-120) were individually transfected into cells at 2 μg each. Transfection was performed with LipofectamineTM 3000 (Invitrogen), and cells were incubated for 48 h. The control group was transfected with empty vector only (Yu et al., 2017).
Table 1

The primers used in this study.

NameSequence (5ʹ-3ʹ)
pFast-N-FCCGCTCGAGCCACCATGGCAAATAACAACGGCAAG
pFast-N-RCGGGGTACCTAGTGATGGTGATGGTGGTGTGCTGAG
GGTGATGCTGTGGCGCGGATCAG
A105-FAGTTACACTGTGGAGTTTGCATTGCCGACGCAACATACTG
A105-RGATCAGACGCACAGTATGTTGCGTCGGCAATGCAAACTCC
A120-FAACTGCATGTCCTGGCGCTA
A120-RGAATGCCAGCCCATCATGCTGAGGGTGCTGC
D-FCACATTGGTGCCCGGGTTGA
D-RGGGATCGAGGTACCCAGAAGC
RT-Nsp9-FCCCTCCATGCCAAACTACCAC
RT-Nsp9-RTTGTCTTCTTTGGGTCCGTCT
GAPDH-FGCAAAGACTGAACCCACTAATTT
GAPDH-RTTGCCTCTGTTGTTACTTGGAGAT
IL-10-FTTCAAACGAAGGACCAGATG
IL-10-RCACAGGGCAGAAATTGATGA
β-actin -FAGGAAGGAGGGCTGGAAGAG
β-actin-RGCGGGACATCAAGGAGAAG
pCA-FCCCATCGATGCCACCATGGCAAATAACAACGGCAAGCAGCAAAAG
pCA-A105RCCGCTCGAGTCAATGATATGATGATGATGTGCTGAGGGTGATGCTGTGGCGCGGATCA
pCA-A120RCCGCTCGAGTCAATGGTGATGGTGATGATGTGCTGAGGGTGCTGCTGTGGCGCGGATCA
RT-N-FAACCAGTCCAGAGGCAAGG
RT-N-RGACAGGGCACAAGTTCCAG
IL-12 p40-FGGGTGGGAACACAAGAGAT
IL-12 p40-RGGCTAAACTTGCCTAGAGGT
The primers used in this study.

Western blot

Cells were lysed in RIPA lysis buffer (Beyotime Biotechnology, China) with a protease inhibitor cocktail (Thermo Fisher, USA). Bradford assays were used to quantify the protein contents. A total of 5 μg of protein was separated by SDS-PAGE (15%) and transferred to a nitrocellulose membrane (Millipore, USA). The membrane was blocked for 1 h in phosphate-buffered saline (TBST) plus 5% milk (BD, USA). N monoclonal antibody (SDOW17,Median, South Korea) was diluted 1:1000 in TBST and incubated with the membrane overnight. The membrane was washed three times in TBST. Then, the membrane was incubated with goat anti-mouse secondary antibody (LI-COR Biosciences, USA) for 1 h in the dark at 37 °C. The membrane was washed three times with TBST. Then, the membrane was analyzed by using an Odyssey Infrared Imaging System (LI-COR Biosciences, USA) (Xie et al., 2014; Hu et al., 2017). The samples were stored at −80 °C.

Protein purification and mass spectrometry

The purification process was carried out according to the manufacturer’s protocol. Briefly, the lysate (pH = 8) was incubated with Q Sepharose Fast Flow (GE Healthcare, USA) for 2 h at 25 °C, and the filtrate was then collected. Subsequently, the filtrate was incubated with Ni Sepharose 6 Fast Flow (GE, USA) for 2 h at 25 °C. Then, the filtrate was washed with increasing concentrations of imidazole (60 and 100 mM imidazole, 25 mM Tris, 500 mM NaCl, pH = 7.4). Finally, the sample was washed with elution buffer (25 mM Tris, 500 mM NaCl, 500 mM imidazole, pH = 7.4) (Fan et al., 2015). The sample was separated using 15% SDS-PAGE, and the target bands were analyzed by LC–MS/MS (Zhang et al., 2017). The LC–MS/MS results were analyzed by Proteome Discoverer (Thermo Fisher, USA)

Real-time PCR

According to the manufacturer’s instructions, total RNA was extracted with TRIzol reagent(Invitrogen, USA). MLV (Takara, Japan) was used to synthesize the cDNA. Real-time PCR was performed on the CFX96TM Real-Time System (Bio-Rad, USA). The primers and calculated method were the same as in the previous report (Xie et al., 2014; Yu et al., 2017).

Recombinant virus rescue

The PRRSV infectious clones were similar to those from a previous report (Zhang et al., 2013). The schematic diagram were shown in the Fig. 1 .The infectious clones were constructed by the fusion PCR. The three mutated plasmids (pokXH-GDA105, pokXH-GDA120, pokXH-GDA105-120)were individually transfected into BHK-21 cells. Transfection was performed with LipofectamineTM 3000 (Invitrogen) according to the manufacturer’s protocol. The cells were collected at 48 h post-transfection as the primary passage (P0). Then, Marc-145 cells were infected by the P0 virus for three passages (P1-P3). The mutations in the rescued virus were confirmed by RT-PCR and sequencing (Zhang et al., 2013).
Fig. 1

The schematic diagramof PRRSV infectious clones.

The schematic diagramof PRRSV infectious clones.

Confocal microscopy

The Marc-145 cells were infected with individual mutant viruses. At 48 h post-infection (hpi), the cells were fixed in methanol, washed five times with PBS and incubated at 4 °C overnight with monoclonal antibody against the N protein (Median, South Korea) (1:400 dilution). Subsequently, the cells were washed in PBS five times and then incubated with fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG (1:100 dilution) for 1 h at 37 °C. Finally, the cells were incubated with DAPI (4ʹ,6-diamidino-2-phenylindole, Thermo Fisher, USA) for 15 min at 37° C (Xie et al., 2014). Fluorescence was observed using a laser scanning confocal microscope (Olympus, Japan).

Multistep growth curve

The multistep growth curve assay was performed as previously reported. Briefly, the Marc-145 cells were infected by P3 at a multiplicity of infection (MOI) of 0.1. The supernatants were collected at certain time points (12, 24, 36, 48, 60, 72 and 84 h) post-infection. The viral titer was measured in the Marc-145 cells. The results were calculated using the Reed-Muench method (Xie et al., 2014).

Data analysis

Data were analyzed as the means ± standard deviations (SD) of three independent experiments. Statistical analyses were done using SPSS software (version 21.0). Tukey’s test was used to evaluate the differences among the groups, and a p value < 0.05 was considered statistically significant.

Results

Expression and purification of N protein from Sf9 cells

Since it is difficult to purify the N protein from virions (Chen et al., 2005), baculovirus expression systems, which are extensively applied in expressing recombinant proteins (Zhang et al., 2017), were used to express the recombinant N protein and confirmed by western blotting with N antibody. To achieve greater protein purity, lysates were first isolated with ion exchange chromatography. Then, the filtrate was incubated with Ni Sepharose 6 Fast Flow (Fig. 2 ). The purification process was performed with reference to the operation manual. Due to degradation, the proteins appeared as two bands after the purification. Both bands were the PRRSV N protein (data no shown).
Fig. 2

Purified recombinant N protein expressed in Sf9 cells. The results of Ni-chelating affinity chromatography. The position of the PRRSV N protein is marked by an arrow.

Purified recombinant N protein expressed in Sf9 cells. The results of Ni-chelating affinity chromatography. The position of the PRRSV N protein is marked by an arrow.

In silico modeling and identification of residue 105 as a phosphorylation site in the N recombinant protein

Since the N protein has proven to be a multiphosphorylated protein, Netphos3.1 (http:/www.cbs.dtu.dk/services/NetPhos/%20) was used to identify the potential N protein phosphorylation sites (Blom et al., 1999; Zengel et al., 2015). Twelve sites were predicted as potential phosphorylation sites (Table 2 ).
Table 2

Summary of the predicted phosphorylation sites in the PRRSV N protein.

Amino acidNet phos (in silico) prediction valueaLC–MS/MS Phosphorylation scoreb
36S0.681ND
59T0.638ND
68T0.936ND
70s0.673ND
77s0.673ND
78s0.500ND
81T0.494ND
89T0.474ND
93S0.481ND
95S0.479ND
99S0.9890.62
100Y0.555ND
101T0.4870.62
105S0.5690.01166
108T0.454ND
111T0.6070.35
118T0.550ND
120S0.8300.004188
122s0.455ND

The NetPhos 3.1 server (http:/www.cbs.dtu.dk/services/NetPhos/%20) was used to predict the PRRSV N protein phosphorylation. Phosphorylation is likely for residues with values >0.5, which are shown in bold.

Likely phosphorylation if score <0.05. ND, not detected.

Summary of the predicted phosphorylation sites in the PRRSV N protein. The NetPhos 3.1 server (http:/www.cbs.dtu.dk/services/NetPhos/%20) was used to predict the PRRSV N protein phosphorylation. Phosphorylation is likely for residues with values >0.5, which are shown in bold. Likely phosphorylation if score <0.05. ND, not detected. Each phosphorylation group results in a mass increase. To identify the phosphorylation sites in PRRSV N protein, the purified protein was analyzed by LC–MS/MS (Thermo Fisher, USA) to yield a moiety of an m/z of 98 Da (H3PO4 or HPO3). The protein was digested by either trypsin or chymotrypsin to yield smaller peptide fragments. The results show that the identified peptides encompass approximately 85.7% of the 129 amino acids of the recombinant protein. As shown in Fig. 3 , by comparison with the theoretical masses, we found two phosphorylation sites. All the sites were located at the C terminus of the N protein. Residue 120 was shown to be phosphorylated in previous research (Han and Yoo, 2014).
Fig. 3

Mapping PRRSV N protein phosphorylation sites by mass spectrometry. N protein was digested by either trypsin or chymotrypsin. (A) Spectra derived from the N protein peptide aa98–113 identified phosphorylated S105 residues. (B) Spectra derived from the N protein peptide aa117–129 identified phosphorylated S120 residues. Lowercase indicates the phosphorylation site.

Mapping PRRSV N protein phosphorylation sites by mass spectrometry. N protein was digested by either trypsin or chymotrypsin. (A) Spectra derived from the N protein peptide aa98–113 identified phosphorylated S105 residues. (B) Spectra derived from the N protein peptide aa117–129 identified phosphorylated S120 residues. Lowercase indicates the phosphorylation site.

The mutations could down-regulate the N-induced IL-10 mRNA

N protein has many functions, such as nuclear localization, up-regulation of IL-10 and virus assembly. IL-10 is a pleiotropic cytokine that may facilitate PRRSV replication (Song et al., 2013). Since it has been proven that the N protein can up-regulate IL-10 (Liu et al., 2015), we constructed four plasmids (pCA-XH-GD, pCA-A105, pCA-A120 and pCA-A105-120) and transfected them into PAMs as previously reported (Yu et al., 2017). Their expression were verified by western blotting (Fig. 4 A). Real-time PCR showed that N protein dephosphorylation down-regulated the IL-10 mRNA level; the IL-10 mRNA level of cells transfected with A105-120 was the lowest observed (Fig. 4B). according to the previous research (Yu et al., 2017),we also detected the IL-12 p40 mRNA level. As shown in the Fig. 4C, There were not significantly different between the viruses.
Fig. 4

The mutation could decrease the IL-10 mRNA level. (A) Western blotting results. PAM (3D4/2) cells were cultivated in a 6-well plate and transfected with 2 μg plasmid. Forty-eight hours post-transfection, the cells were lysed by RIPA lysis buffer. The results showed that N protein could be detected in all samples. (B,C) Total RNA was extracted and subjected to real-time PCR analysis. The fold change in IL-10 gene levels(B) or IL-12p40mRNA (C)compared to β-actin were determined. The data shown represent the mean ± SD (n=3) (*, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison with the XH-GD group).

The mutation could decrease the IL-10 mRNA level. (A) Western blotting results. PAM (3D4/2) cells were cultivated in a 6-well plate and transfected with 2 μg plasmid. Forty-eight hours post-transfection, the cells were lysed by RIPA lysis buffer. The results showed that N protein could be detected in all samples. (B,C) Total RNA was extracted and subjected to real-time PCR analysis. The fold change in IL-10 gene levels(B) or IL-12p40mRNA (C)compared to β-actin were determined. The data shown represent the mean ± SD (n=3) (*, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison with the XH-GD group).

N protein phosphorylation did not affect viral viability and infectivity

According to previous reports, Mutated residue 120 of N protein did not affect viral infectivity and viability (Liu et al., 2017). However, we found that reside 120 was not a conserved site and that the deletion of residue 120 did not affect virus viability (Tan et al., 2011). To study the function of the phosphorylation sites, three mutant plasmids were constructed, namely, pokXH-GDA105 (S105A), pokXH-GDA120 (S120A) and pokXH-GDA105-120 (S015A, S120A). The plasmids were transfected into BHK-21 cells. The cells were collected and passaged in Marc-145 cells for up to three passages. The sequencing results confirmed that the substitutions were stable in the three mutant viruses. The western blotting results show that all mutated viruses expressed the N protein at 48 hpi (Fig. 5 ). The results indicated that the mutations did not affect the recovery of PRRSV.
Fig. 5

Western blotting results. The cells were cultivated in a 6-well plate and incubated with virus. Forty-eight hours post-infection, the cells were lysed by RIPA lysis buffer. The results show that all samples contain the N protein, indicating that all the mutant viruses could be rescued.

Western blotting results. The cells were cultivated in a 6-well plate and incubated with virus. Forty-eight hours post-infection, the cells were lysed by RIPA lysis buffer. The results show that all samples contain the N protein, indicating that all the mutant viruses could be rescued.

The phosphorylation of N protein impaired viral growth

A previous report showed that residue 120 was important for the viral replication ability (Liu et al., 2017). Therefore, we questioned whether alteration of residue 105 would also affect the viral growth ability. Multistep growth kinetics were measured in infected Marc-145 cells in three independent experiments. Viral titers were determined by TCID50. The wild-type virus reached a peak titer at 48 hpi. The other viruses reached peak titers at 60 hpi. The wild-type virus showed a stronger growth ability than the mutated viruses. There were significant differences between the wild-type virus and A105, A120 and A105-120 viruses at 48 hpi (Fig. 6 A). Compared with the A105 and A120, A105-120 showed lower viral growth. For quantitative analysis of PRRSV, total RNA was extracted for real-time PCR as previously reported (Xie et al., 2014). The real-time PCR results showed that the Nsp9 gene level was lowest in A105-120 (Fig. 6B). Then,the PAMs(primary PAMs) were infected with 0.1MOI PRRSV. At 48 hpi, total RNA was extracted for real-time PCR. The results were similar with the Marc-145, the mutation reduce the viral gene level (Fig. 7 A),but did not impaired the IL-10 mRNA level (Fig. 7B). These results mirror those of the multistep growth kinetics. This finding indicated that residue 105 could affect viral growth, similarly to residue 120, and that the phosphorylation of N may play an important role in the virus life cycle.
Fig. 6

Virological characteristics of the N protein mutants. (A) Multistep kinetics of mutant viruses and wild-type virus in Marc-145 cells. Cells were infected with PRRSV at MOI 0.1. The supernatants were collected at various time points and titrated. The TCID50 was calculated by the Reed-Muench method. (B) Total RNA was extracted and subjected to the real-time PCR analysis, and the fold change in PRRSV Nsp9 gene levels compared with GAPDH was determined. The data shown represent the mean ± SD (n = 3) (*, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison with the XH-GD group).

Fig. 7

The qPCR result of infected PAMs. Cells were infected with PRRSV at MOI 0.1.Total RNA was extracted at 48h post-infection and subjected to the real-time PCR analysis, (A) The fold change in PRRSV N gene levels level compared with βoactin was determined;(B) Level of IL-10 mRNA production was calculated after normalization to pokXH-GD.The data shown represent the mean ± SD (n = 3) (*, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison with the XH-GD group).

Virological characteristics of the N protein mutants. (A) Multistep kinetics of mutant viruses and wild-type virus in Marc-145 cells. Cells were infected with PRRSV at MOI 0.1. The supernatants were collected at various time points and titrated. The TCID50 was calculated by the Reed-Muench method. (B) Total RNA was extracted and subjected to the real-time PCR analysis, and the fold change in PRRSV Nsp9 gene levels compared with GAPDH was determined. The data shown represent the mean ± SD (n = 3) (*, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison with the XH-GD group). The qPCR result of infected PAMs. Cells were infected with PRRSV at MOI 0.1.Total RNA was extracted at 48h post-infection and subjected to the real-time PCR analysis, (A) The fold change in PRRSV N gene levels level compared with βoactin was determined;(B) Level of IL-10 mRNA production was calculated after normalization to pokXH-GD.The data shown represent the mean ± SD (n = 3) (*, P < 0.05; **, P < 0.01; ***, P < 0.001 in comparison with the XH-GD group).

Mutation of residues 105 and 120 did not affect the N protein distribution in cells

Because residue 105 and residue 120 are close to the N protein nuclear export signal (Han and Yoo, 2014), we wished to further investigate whether these mutations would affect the N protein distribution in cells. The Marc-145 cells were incubated with A105-120 and wild-type virus at 0.1 MOI. The N protein signal was examined using an indirect immunofluorescence assay (Fig. 8 ). N protein was detected in the cytoplasm and nuclei. There are not significant differences in the localization of A105-120 and wild-type virus. This finding indicated that the mutations did not interfere in N protein distribution.
Fig. 8

Marc-145 cells infected with A105-120 or XH-GD at an MOI of 0.1. At 48 hpi, the infected cells were fixed with PBS and incubated with mouse anti-N mAb, followed by FITC goat anti-mouse IgG (H + L).The nuclei were stained with DAPI.

Marc-145 cells infected with A105-120 or XH-GD at an MOI of 0.1. At 48 hpi, the infected cells were fixed with PBS and incubated with mouse anti-N mAb, followed by FITC goat anti-mouse IgG (H + L).The nuclei were stained with DAPI.

Discussion

Post-translational modification is important for protein function (Bittremieux et al., 2017). As an abundant protein in PRRSV, N protein has been proven to have many functions, including regulation of host cytokines, connection with other viral proteins and so on (Liu et al., 2016; Han and Yoo, 2014). However, the modification of the N protein are still unclear, especially the phosphorylation sites. Determining the modifications of the N protein would be helpful for understanding the life cycle of PRRSV. As a protein modification, phosphorylation is important for regulating protein function and virus biology. In this study, we found two phosphorylation sites by LC–MS/MS, including Ser105 and Ser120. We confirmed that the N protein was a multiphosphorylated protein, as previously reported (Wootton et al., 2002). There are many viruses, such as PRRSV, SARS and IBV, contain the nucleocapsid proteins that have been proven to be phosphorylated proteins. Many of these nucleocapsid proteins were found to play a vital function during the viral life cycle, such as in mumps virus or Hanta virus (Zengel et al., 2015). Since the N protein could up-regulate IL-10, according to previous research (Yu et al., 2017), PAMs were transfected with four plasmids. The qPCR results suggested that the mutation down-regulated the induction of IL-10 mRNA. However, the IL-10 mRNA qPCR result of infected PAMs were different with the transfected PAMs.One possible reason is that the other proteins, such as GP5 and Nsp9, could regulate the IL-10 (Burgara-Estrella et al., 2013). Previous reports have demonstrated that Ser120 did not affect the recovery of virus (Liu et al., 2017; Tan et al., 2011). However, when comparing the different strains, we found that residue 105 was more conserved than residue 120 (Fig. 9 ). This indicates that residue 105 may be a major phosphorylation site. Therefore, we substituted Ser105 and Ser120 with Ala individually and together. The three mutant viruses were rescued from Marc-145 cells. It is indicated that the phosphorylation of N protein may not be essential for the viability of PRRSV. Mutated the N phosphorylation sites could decrease the viral titier, it is proved that the mutations could impair the viral replication ability (Fig. 6).
Fig. 9

Amino acid sequence alignments of the N protein from isolates that are available in the National Center for Biotechnological Information (NCBI) database. Residues 105 and 120 are shown in brown and red. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).

Amino acid sequence alignments of the N protein from isolates that are available in the National Center for Biotechnological Information (NCBI) database. Residues 105 and 120 are shown in brown and red. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article). According to previous reports, there are three functions of N protein phosphorylation, which may fall into the categories of modulating its nuclear localization, regulating host cytokines and regulating the protein’s binding to viral RNA (Liu et al., 2015; Wootton et al., 2002). Our results showed that the mutations did not change the distribution of N protein in infected cells. The poor growth ability may be related to host cytokine activity or protein binding activity to viral RNA. In terms of binding activity to viral RNA, as we know, the modifications and structure of the PRRSV N protein are similar to those of Coronavirus (Chang et al., 2005). It is possible that they have the similar mechanism. In the case of IBV or MHV, the phosphorylated N protein may have a higher binding affinity than the unphosphorylated N protein for genomic RNA (Spencer et al., 2008). Therefore, we speculated that the phosphorylation modification may help N protein to bind to viral RNA, and hence the mutation to the phosphorylated residue would decrease this binding. However, the mechanism underlying the poor growth ability of these mutants still needs further investigation. In conclusion, through a combination of affinity purification and LC–MS/MS, our results show that N protein expressed in insect cells contains two phosphorylation sites, including one novel phosphorylation site. Our qPCR results showed that constitutive dephosphorylation decreases the N-induced expression of IL-10 mRNA in transfected PAMs. Utilizing reverse genetics, we found that Ser105 and Ser120 did not affect virus infection and viability but does play a role in viral growth. Those findings indicated that phosphorylation at these sites affects N protein functions. The mechanism needs further investigation. Since the MS/MS method has shortcomings, other possible phosphorylation sites within the N protein cannot be ruled out. These studies will be helpful for understanding the role of the N protein in the PRRSV life cycle.

Author contributions

Designed experiments: YC. Performed the experiments: YC, XX, QL, SF. Analyzed the data: XH, SH. Wrote the manuscript: YC. Revised the manuscript: GZ, XH.

Conflict of interest

The authors declare no conflicts of interest.
  27 in total

1.  The integrity of PRRSV nucleocapsid protein is necessary for up-regulation of optimal interleukin-10 through NF-κB and p38 MAPK pathways in porcine alveolar macrophages.

Authors:  Jiang Yu; Yanyan Liu; Yuyu Zhang; Xiwang Zhu; Sufang Ren; Lihui Guo; Xing Liu; Wenbo Sun; Zhi Chen; Xiaoyan Cong; Lei Chen; Jianli Shi; Yijun Du; Jun Li; Jiaqiang Wu; Jinbao Wang
Journal:  Microb Pathog       Date:  2017-04-27       Impact factor: 3.738

2.  Inhibition of porcine reproductive and respiratory syndrome virus by specific siRNA targeting Nsp9 gene.

Authors:  Jiexiong Xie; Han Zhou; Jin Cui; Yao Chen; Minze Zhang; Shengchao Deng; Pei Zhou; Shuo Su; Guihong Zhang
Journal:  Infect Genet Evol       Date:  2014-08-20       Impact factor: 3.342

3.  Roles of Phosphorylation of the Nucleocapsid Protein of Mumps Virus in Regulating Viral RNA Transcription and Replication.

Authors:  James Zengel; Adrian Pickar; Pei Xu; Alita Lin; Biao He
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

4.  The Nucleocapsid Protein and Nonstructural Protein 10 of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Enhance CD83 Production via NF-κB and Sp1 Signaling Pathways.

Authors:  Xi Chen; Qiaoya Zhang; Juan Bai; Yongxiang Zhao; Xianwei Wang; Haiyan Wang; Ping Jiang
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

5.  Mutagenesis analysis of porcine reproductive and respiratory syndrome virus nonstructural protein 7.

Authors:  Minze Zhang; Zhenpeng Cao; Jiexiong Xie; Wanjun Zhu; Pei Zhou; Honglang Gu; Long Sun; Shuo Su; Guihong Zhang
Journal:  Virus Genes       Date:  2013-07-28       Impact factor: 2.332

6.  Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein Interacts with Nsp9 and Cellular DHX9 To Regulate Viral RNA Synthesis.

Authors:  Long Liu; Jiao Tian; Hao Nan; Mengmeng Tian; Yuan Li; Xiaodong Xu; Baicheng Huang; Enmin Zhou; Julian A Hiscox; Hongying Chen
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

7.  Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10.

Authors:  Alexel Burgara-Estrella; Ivan Díaz; Irene M Rodríguez-Gómez; Sabine E Essler; Jesús Hernández; Enric Mateu
Journal:  Viruses       Date:  2013-02-11       Impact factor: 5.048

8.  A highly pathogenic porcine reproductive and respiratory syndrome virus candidate vaccine based on Japanese encephalitis virus replicon system.

Authors:  Pingsheng Hu; Xiaoming Chen; Lihong Huang; Shukai Liu; Fuyu Zang; Jinchao Xing; Youyue Zhang; Jiaqi Liang; Guihong Zhang; Ming Liao; Wenbao Qi
Journal:  PeerJ       Date:  2017-07-20       Impact factor: 2.984

Review 9.  Engineering the PRRS virus genome: updates and perspectives.

Authors:  Mingyuan Han; Dongwan Yoo
Journal:  Vet Microbiol       Date:  2014-10-23       Impact factor: 3.293

10.  Role of phosphorylation clusters in the biology of the coronavirus infectious bronchitis virus nucleocapsid protein.

Authors:  Kelly-Anne Spencer; Michael Dee; Paul Britton; Julian A Hiscox
Journal:  Virology       Date:  2007-11-01       Impact factor: 3.616

View more
  2 in total

1.  The phosphorylation of the N protein could affect PRRSV virulence in vivo.

Authors:  Yao Chen; Zhiqing Yu; Heyou Yi; Yingfang Wei; Xiaoliang Han; Qi Li; Chihai Ji; Junmin Huang; Qiwei Deng; Yixin Liu; Mengkai Cai; Shuyi He; Chunquan Ma; Guihong Zhang
Journal:  Vet Microbiol       Date:  2019-03-14       Impact factor: 3.293

2.  A novel amino acid site of N protein could affect the PRRSV-2 replication by regulating the viral RNA transcription.

Authors:  Hua Deng; Ning Xin; Fancong Zeng; Feng Wen; Heyou Yi; Chunquan Ma; Shujian Huang; Guihong Zhang; Yao Chen
Journal:  BMC Vet Res       Date:  2022-05-11       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.